Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chapman

Showing results (851-860 of 891) with videos related to

Pageof 90
Sort By:
Neuropharmacology|June 23, 2010
A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in ratsXu-Feng Zhang, Char-Chang Shieh, Mark L Chapman, et al.
Journal of Pineal Research|December 20, 2024
3-Month Melatonin Supplementation to Reduce Brain Oxidative Stress and Improve Sleep in Mild Cognitive Impairment: A Randomised Controlled Feasibility TrialZoe Menczel Schrire, Craig L Phillips, Shantel L Duffy, et al.
Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.
BMJ Open|February 11, 2021
Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled studyZoe Menczel Schrire, Craig L Phillips, Shantel L Duffy, et al.
Human Molecular Genetics|August 30, 2007
Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria contentKurt J De Vos, Anna L Chapman, Maria E Tennant, et al.
Journal of Pineal Research|December 19, 2021
Safety of higher doses of melatonin in adults: A systematic review and meta-analysisZoe Menczel Schrire, Craig L Phillips, Julia L Chapman, et al.
Medchemcomm|August 16, 2018
The discovery of a potent Na<sub>v</sub>1.3 inhibitor with good oral pharmacokineticsD C Pryde, N A Swain, P A Stupple, et al.
Regulatory Toxicology and Pharmacology : RTP|November 22, 2011
The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primatesKathryn L Chapman, Laura Andrews, Jeffrey J Bajramovic, et al.
The EMBO Journal|May 30, 2025
Structural basis of Fanconi anemia pathway activation by FANCMRohan Bythell-Douglas, Sylvie van Twest, Lara Abbouche, et al.
Sleep Medicine Reviews|November 4, 2019
Magnesium supplementation for the treatment of restless legs syndrome and periodic limb movement disorder: A systematic reviewNathaniel S Marshall, Yasmina Serinel, Roo Killick, et al.
Pageof 90

Showing results (851-860 of 891) with videos related to

Sort By:
Pageof 90
Neuropharmacology|June 23, 2010
A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in ratsXu-Feng Zhang, Char-Chang Shieh, Mark L Chapman, et al.
Journal of Pineal Research|December 20, 2024
3-Month Melatonin Supplementation to Reduce Brain Oxidative Stress and Improve Sleep in Mild Cognitive Impairment: A Randomised Controlled Feasibility TrialZoe Menczel Schrire, Craig L Phillips, Shantel L Duffy, et al.
Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.
BMJ Open|February 11, 2021
Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled studyZoe Menczel Schrire, Craig L Phillips, Shantel L Duffy, et al.
Human Molecular Genetics|August 30, 2007
Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria contentKurt J De Vos, Anna L Chapman, Maria E Tennant, et al.
Journal of Pineal Research|December 19, 2021
Safety of higher doses of melatonin in adults: A systematic review and meta-analysisZoe Menczel Schrire, Craig L Phillips, Julia L Chapman, et al.
Medchemcomm|August 16, 2018
The discovery of a potent Na<sub>v</sub>1.3 inhibitor with good oral pharmacokineticsD C Pryde, N A Swain, P A Stupple, et al.
Regulatory Toxicology and Pharmacology : RTP|November 22, 2011
The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primatesKathryn L Chapman, Laura Andrews, Jeffrey J Bajramovic, et al.
The EMBO Journal|May 30, 2025
Structural basis of Fanconi anemia pathway activation by FANCMRohan Bythell-Douglas, Sylvie van Twest, Lara Abbouche, et al.
Sleep Medicine Reviews|November 4, 2019
Magnesium supplementation for the treatment of restless legs syndrome and periodic limb movement disorder: A systematic reviewNathaniel S Marshall, Yasmina Serinel, Roo Killick, et al.
Pageof 90